Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:ONS

Oncobiologics (ONS) Stock Price, News & Analysis

Oncobiologics logo

About Oncobiologics Stock (NASDAQ:ONS)

Advanced Chart

Key Stats

Today's Range
$1.71
$1.82
50-Day Range
$0.72
$7.40
52-Week Range
$0.57
$1.53
Volume
595,797 shs
Average Volume
69,024 shs
Market Capitalization
$128.52 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive ONS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Oncobiologics and its competitors with MarketBeat's FREE daily newsletter.

ONS Stock News Headlines

The #1 AI Energy Stock
Nearly $600 billion is projected to be spent on AI data centers this year. That's because the ones being built now will dwarf everything that came before them. Thanks to AI's ravenous hunger for power … They are beginning to morph into sprawling behemoths.
Are Away Carry-Ons Worth the Hype?
ONS - the Office of National Statistics
See More Headlines

ONS Stock Analysis - Frequently Asked Questions

Oncobiologics (ONS) raised $35 million in an initial public offering (IPO) on Friday, May 13th 2016. The company issued 5,800,000 shares at $6.00 per share. Jefferies and Barclays acted as the underwriters for the IPO and Cantor Fitzgerald & Co. was co-manager.

Based on aggregate information from My MarketBeat watchlists, some other companies that Oncobiologics investors own include CRISPR Therapeutics (CRSP), Network-1 Technologies (NTIP), Allena Pharmaceuticals (ALNA), Intra-Cellular Therapies (ITCI), Cidara Therapeutics (CDTX), Neuralstem (CUR) and Exelixis (EXEL).

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Biological Products, Except Diagnostic
Sub-Industry
N/A
Current Symbol
NASDAQ:ONS
Previous Symbol
NYSE:ONS
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$38.84 million
Net Margins
-464.47%
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$3.81 million
Price / Cash Flow
N/A
Book Value
($1.36) per share
Price / Book
-1.31

Miscellaneous

Free Float
N/A
Market Cap
$128.52 million
Optionable
Not Optionable
Beta
-0.27
These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

This page (NASDAQ:ONS) was last updated on 7/5/2025 by MarketBeat.com Staff
From Our Partners